Form D · Biotechnology

GI DYNAMICS, INC.

Boston, MA · CIK 0001245791

Offering snapshot reported Oct 5, 2018 · SEC filing

Reported sold
$2.16M
Offering amount: $5M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 20, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 5, 2018Initial$2,160,000No comparison1SEC filing
Feb 7, 2018Initial$699,442No comparison1SEC filing
Jul 22, 2013Initial$34,755,000No comparison13SEC filing
Sep 15, 2011Initial$37,504,548No comparison9SEC filing
Jan 7, 2010Initial$15,000,000No comparison1SEC filing
Feb 11, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Jun 5, 2006PaperNot reportedNo comparisonNot reported

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-322975

Source: Form D, filed Oct 5, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Timothy Barberich Director
Graham John Bradley Director
Michael Carusi Director
Robert W. Crane Executive
Brian Halak Director
Kedir Kadhiresan Director
Anne Keating Director
Andy Levine Director, Executive
Jack Meyer Director
Daniel Moore Director
Stuge Oern Director
Jonathan Osgood Director
Stuart A. Randle Director, Executive
Scott Schorer Executive
Juliet Thompson Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
745 Atlantic Ave Office No. 708
Boston, MA, 02111